Suppr超能文献

磷脂酶A2抑制剂对小鼠肠道细胞增殖和凋亡的影响。

The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells.

作者信息

Longo W E, Grossmann E M, Erickson B, Panesar N, Mazuski J E, Kaminski D L

机构信息

Department of Surgery, St. Louis University School of Medicine and Health Sciences Center, St. Louis, Missouri, 63110-0250, USA.

出版信息

J Surg Res. 1999 Jun 1;84(1):51-6. doi: 10.1006/jsre.1999.5603.

Abstract

BACKGROUND

Group II phospholipase A2 (PLA2) enzymes, the rate controlling enzymes in arachidonic acid metabolism, have been well characterized and subdivided into secretory 14-kDa PLA2 (sPLA2) and cytoplasmic 85-kDa PLA2 (cPLA2). Previous research has demonstrated increased PLA2 in colorectal tumors. The present study was performed to determine the effect of specific PLA2 inhibitors on the proliferation and induction of apoptosis of intestinal epithelial cells.

METHODS

A continuously proliferating rat small intestinal cell line (IEC-18) and a mouse colon cancer cell line (WB-2054-M4) were utilized for these experiments. The cells were placed in microwells with serum-free or serum-supplemented media. The effects of serum on proliferation were then evaluated in the presence of the cPLA2 inhibitor, methylarachidonyl fluorophosphate (MAFP), or the sPLA2 inhibitor p-bromophenacyl bromide (BPB). The sPLA2 and cPLA2 protein was estimated by Western blotting. Proliferation of intestinal cells was quantitated by incorporation of [3H]thymidine into DNA and PLA2 activity was evaluated by quantitating arachidonic acid formation and prostaglandin E2 production.

RESULTS

Western blotting of IEC-18 and WB-2054 cell protein demonstrated sPLA2 and cPLA2 enzyme in cells incubated in media containing 10% serum. Spontaneous DNA synthesis was present in both cell lines and serum consistently increased proliferation. In IEC-18 cells [3H]thymidine incorporation stimulated by serum was inhibited by MAFP and BPB, while in the malignant cell line, proliferation was inhibited only by BPB. BPB, but not MAFP, produced a dose-dependent increase in apoptotic ratios in both cell lines. Arachidonic acid and PGE2 formation, stimulated by serum, was inhibited by MAFP and BPB.

CONCLUSIONS

A differential effect on intestinal cell mitogenesis was seen with different PLA2 inhibitors. The sPLA2 inhibitor, but not the cPLA2 inhibitor, significantly inhibited [3H]thymidine incorporation in the malignant cell line. This occurred with an induction of apoptosis. sPLA2 inhibitors may be specific inhibitors of growth of malignant cells. The inhibition of arachidonic acid and PGE2 production did not correlate with the inhibition of proliferation, suggesting that the two processes may be unrelated.

摘要

背景

II 型磷脂酶 A2(PLA2)酶是花生四烯酸代谢中的限速酶,已得到充分表征,并细分为分泌型 14 kDa PLA2(sPLA2)和胞质型 85 kDa PLA2(cPLA2)。先前的研究表明,结直肠肿瘤中 PLA2 水平升高。本研究旨在确定特定 PLA2 抑制剂对肠上皮细胞增殖和凋亡诱导的影响。

方法

本实验使用了一种持续增殖的大鼠小肠细胞系(IEC - 18)和一种小鼠结肠癌细胞系(WB - 2054 - M4)。将细胞置于无血清或补充血清的培养基的微孔板中。然后在存在 cPLA2 抑制剂氟磷酸甲花生四烯酯(MAFP)或 sPLA2 抑制剂对溴苯甲酰溴(BPB)的情况下,评估血清对增殖的影响。通过蛋白质印迹法估计 sPLA2 和 cPLA2 蛋白。通过将[3H]胸苷掺入 DNA 来定量肠细胞的增殖,并通过定量花生四烯酸形成和前列腺素 E2 产生来评估 PLA2 活性。

结果

对 IEC - 18 和 WB - 2054 细胞蛋白进行蛋白质印迹分析表明,在含有 10%血清的培养基中培养的细胞中存在 sPLA2 和 cPLA2 酶。两种细胞系均存在自发 DNA 合成,血清持续增加细胞增殖。在 IEC - 18 细胞中,血清刺激的[3H]胸苷掺入受到 MAFP 和 BPB 的抑制,而在恶性细胞系中,增殖仅受到 BPB 的抑制。BPB 而非 MAFP 在两种细胞系中均产生剂量依赖性的凋亡率增加。血清刺激产生的花生四烯酸和 PGE2 形成受到 MAFP 和 BPB 的抑制。

结论

不同的 PLA2 抑制剂对肠细胞有丝分裂产生不同的影响。sPLA2 抑制剂而非 cPLA2 抑制剂显著抑制恶性细胞系中的[3H]胸苷掺入。这伴随着凋亡的诱导。sPLA2 抑制剂可能是恶性细胞生长的特异性抑制剂。花生四烯酸和 PGE2 产生的抑制与增殖的抑制不相关,表明这两个过程可能无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验